Abstract

9
Coral disease is often studied at scales ranging from single colonies to the entire 10 reef. This is particularly true for studies following disease progression through time.
11
To gain a mechanistic understanding of key steps underlying infection dynamics, it 12 is necessary to study disease progression, and host-pathogen interactions, at 13 relevant microbial scales. Here we provide a dynamic view of the interaction 14 between the model coral pathogen Vibrio coralliilyticus and its coral host Pocillopora 15 damicornis at unprecedented spatial and temporal scales. This view is achieved 16 using a novel microfluidics-based system specifically designed to allow microscopic 17 study of coral infection in-vivo under controlled environmental conditions. Analysis 18 of exudates continuously collected at the system's outflow, allows a detailed 19 biochemical and microbial analyses coupled to the microscopic observations of the 20 disease progression. The resulting multilayered dataset provides the most detailed 21 description of a coral infection to-date, revealing distinct pathogenic processes as 22 well as the defensive behavior of the coral host. We provide evidence that infection 23 in this system occurs following ingestion of the pathogen, and may then progress 24 through the gastrovascular system. We further show infection may spread when 25 pathogens colonize lesions in the host tissue. Copious spewing of pathogen-laden 26 mucus from the polyp mouths results in effective expulsion of the pathogen from the 27 gastrovascular system, possibly serving as a first line of defense. A secondary 28 defense mechanism entails the severing of calicoblastic connective tissues resulting 29 in the controlled isolation of diseased polyps, or the survival of individual polyps 30 within infected colonies. Further investigations of coral-pathogen interactions at 31 these scales will help to elucidate the complex interactions underlying coral disease, 32 as we as the versatile adaptive response of the coral ecosystems to fluctuating 33 environments. 34
Introduction 35
Coral reefs are currently undergoing an unprecedented decline driven by local and 36 global changes to their environment 1 . Reef building corals, commonly described as 37 holobionts, form a complex relationship with photosynthesizing dinoflagellates 38 (Symbiodinium spp.) and a consortium of microbial partners 2 . Shifts in 39 environmental conditions may lead to the breakdown of these symbiotic relations, 40 often with catastrophic consequences for the coral colony. Such processes, 41 collectively termed coral disease 3, 4 , may be manifested as a loss of the algal 42 symbionts (coral bleaching) 5 , or as damage to the coral colony due to various forms 43 of necrotic loss of coral tissue 2 . On large scales, these processes may result in loss of 44 coral cover, ultimately leading to the degradation of the reef structure and the loss 45 of associated ecological and societal services 4, 6, 7 . 46
Many coral diseases are linked to specific pathogens whose abundance and 47 virulence increase in response to environmental changes. Such changes may include 48 nutrient loading, pollution, and temperature shifts [8] [9] [10] [11] . One of the best characterized 49 coral diseases is the infection of the Indo-Pacific coral Pocillopora damicornis by the 50 bacterial pathogen Vibrio coralliilyticus 9, 12, 13 . The virulence of V. coralliilyticus is 51 known to be positively correlated with increased temperatures 9, 14-16 . Increased 52 ambient temperatures are further linked to accelerated vibrio growth rates 9 , 53 enhanced chemotaxis and chemokinesis 17 , and secretion of matrix metalloproteases 54 (MMPs) 18 . Nevertheless, a mechanistic understanding linking these traits to coral 55 infection and disease progress is still lacking. 56
Many coral disease studies focus on monitoring coral colonies for the appearance of 57 macroscopic signs of disease. These may include various forms of tissue 58 discoloration, loss of the algal symbionts, or loss of tissue integrity 19, 20 . This 59 tendency for macroscale studies is derived to a large extent from the complexity of 60 the coral holobiont 21, 22 , and the difficulty in establishing a tractable model system 61 facilitating more detailed observations 22, 23 . Currently, the main available tool 62 enabling to link a potential pathogen to the site of tissue damage and to the host 63 response is histopathology 23 . However, as such disease manifestations only appear 64 at advanced stages of the infection process, their use as disease indicators fails to 65 capture the early stages of pathogen colonization and disease initiation 23 . We are 66 thus lacking a mechanistic understanding of key steps in the infection process, 67 including e.g. site of initial colonization, possible functions of specific disease 68 markers such as MMP's, or where bacterial chemotaxis may come into play. 69
Furthermore, there are still major knowledge gaps in our understanding of coral 70 response at the onset of pathogenic infection. 71
Here we present a new microfluidic system, the Microfluidic Coral Infection (MCI) 72 platform, developed specifically to tackle question related to the interaction 73 between a bacterial pathogen and a coral colony at high spatio-temporal 74
resolutions. This platform has several features distinguishing it from the previously 75 published coral-on-a-chip (CoC) system 24 . The larger chamber volume and higher 76 flow rates of the MCI, as compared to the CoC, facilitate the incubation of small coral 77 fragments, preserving the colonial morphology of the coral colony. Moreover, the 78 MCI design allows the continuous collection of exudates of the system for 79 downstream analysis. The MCI further allows the incubation and tracking of up to 6 80 individual coral fragments in separate chambers, facilitating flexible experimental 81 design. Using the MCI system we track the microscopic encounter between the 82 bacterial pathogen V. coralliilyticus and its coral host P. damicornis. Coupling the 83 resulting time-lapse microscopic imaging with biochemical and microbial analyses 84 of the system's outflow we identify early stages of the infection process that were 85 not previously described. These results bring us a step closer towards a mechanistic 86 understanding of microbial disease processes in reef building corals. 87
Results
88
Live imaging of coral infection 89
The progression of bacterial infection of small coral fragments was enabled using 90 the MCI platform ( Figure 1; Supplementary figure 1) . To demonstrate the 91 robustness of this system, healthy P. damicornis fragments were incubated under 92 controlled environmental conditions (temperature, light, flow, and water quality). 
107
Infection progress is tracked using epifluorescence and light microscopy at set intervals. D.
108
Image analysis is used to quantify signal intensity and localization in all channels No morphological or behavioral changes were observed in non-challenged control 122 fragments from all experiments ( Fig. 2A; supplementary video 1) . In fragments 123 challenged by V. fischeri (10 8 cells/ml), accumulation of DsRed-labelled bacteria was 124 observed in the polyp pharynx over the 1 st hour of inoculation. This was followed by 125 moderate spewing of bacterial-laden mucus from all polyps (Fig 2B; supplementary  126 video 2). No other morphological or behavioral changes were observed. Figure 5D ; 233 Supplementary figures 3A, 4A), with a corresponding decrease in MMP activity (Fig.  234 5F; Supplementary figure 3B, 4B). In challenged, symptomatic fragments a 235 subsequent rise of up to 10 fold in MMP activity was regularly observed starting at 236 4-6 h post inoculation ( Fig. 5F; Figure 6 ; Supplementary figure 4B). This increase 237 was followed by an increase in bacterial load of up to half an order of magnitude at 238 7-10 hours post inoculation ( Figure 5D; Supplementary figure 4A ). These late 239 increase in bacterial abundance and MMP activity were not observed in either the 240 challenged, non-symptomatic fragments or in fragments challenged with V. fischeri. 241
Comparing total and DsRed-labeled bacterial numbers in the outflow of one 242 experiment revealed that the portion of DsRed labelled bacterial cells went down 243 from 100% labeling in the inoculum to 70-90% in the following 8h, and further 244 decrease to 60% during the subsequent rise in bacterial abundance starting at 9.5 h 245 from inoculation (Supplementary Figure 5) . 246
By integrating the various measurement and observations from all MCI experiments 247 into a single timeline we were able to generate the most detailed description to-date 248 of the infection of a reef building coral by a bacterial pathogen (Fig. 6 ). This unified 249 timeline reveals the conservation of the different stages described here, as well as 250 some variability in the relative timing of specific events, particularly in the later 251 stages. From this integrated timeline it is evident that initial polyp contraction and 252 mucus spewing was an immediate response shared by all fragments regardless of 253 their ultimate fate. The rise in MMP activity was always preceded by the onset of 254 tissue lysis, and was generally preceded by GFP decay. The rise in bacterial 255 abundance in the effluent was generally observed following the rise in MMP activity. 256
In the majority of actively infected fragments, the entire infection process was 257 complete within 10-15 hours following inoculation. 
Discussion 268
Coral disease progression is often studied at scales ranging from single colonies to 269 the entire reef, thus overlooking the microscale processes governing host-pathogen 270 interactions. While important insights into disease etiology have been gained by 271 careful pathological and histological studies 23, 27-30 , such studies are mostly limited 272 to snapshots of the disease process at acute and morphologically recognizable 273 phases 8, 13, 31-33 . Thus, an in vivo description of the sequence of microscopic events 274 underlying the process of coral infection is still missing. The current work aims to 275 bridge this gap, by studying coral disease under controlled laboratory conditions, at 276 temporal and spatial scales relevant to the microscopic interactions between a 277 bacterial pathogen and its coral host. 278
Using live-imaging microscopy we are able, for the first time, to visualize V. 279 coralliilyticus as it colonizes and infects its coral host. Rather than colonizing the 280 entire colony surface, we show that bacterial accumulation occurs primarily at the 281 polyp pharynx, which points towards a gastrovascular route of infection. This is in 282 agreement with observations reported in our previous work, demonstrating 283 accumulation of V. coralliilyticus in the gastrovascular cavity of micropropagated P. 284 damicornis polyps 24 . Following inoculation the majority of coral fragments displayed 285 a clear pathology leading to colony disintegration followed by the release of V. 286 coralliilyticus cells to the surrounding water. Accumulation at the coral pharynx was 287 also observed in coral fragments challenged with V. fischeri, but to a lesser extent 288 and no apparent pathology. Colonization of the colony surface in our experiments 289 appeared to be limited to sites of tissue lesions, which may serve as hotspots of 290 bacterial infection. 291
Beyond tracking of the bacterial pathogen, the MCI provides us with the unique 292 ability to observe microscale patterns of coral behavior, a subject that is rarely 293 considered in the context of coral disease. We were thus able to describe and 294 characterize the sequence of behavioral responses of the coral host following a 295 bacterial challenge. We observed specific coral reactions immediately following 296 inoculation with pathogenic V. coralliilyticus, particularly the retraction of coral 297 polyps into their calices followed by mucus spewing, that were distinct from those 298 observed following a challenge by the non-pathogenic V. fischeri. Polyp retraction is 299 a universal response of corals to physical or environmental stress 34 , indicating that 300 the coral is sensing, and responding to, the presence of pathogens or their exudates. 301
Moreover, as polyp retraction minimizes intake of water into the polyp 302 gastrovascular system, and thus the internalization of planktonic food [35] [36] [37] In all V. coralliilyticus-challenged fragments, mucus spewing was invariably followed 315 by stretching of ceonosarc tissues. In symptomatic fragments, this ultimately led to 316 tearing of the tissue and separation of adjacent polyps. Surprisingly, many of these 317 isolated polyps survived, some remaining attached to the skeleton while most 318 undergoing polyp bail-out 24, 26 . Notably, bailed out polyps collected and maintained 319 in filtered sea-water following infection experiments remained viable for over two 320 weeks, suggesting that these polyps were indeed able to overcome the invading 321 pathogen. Polyp separation thus provides the coral with an additional defense layer, 322 enabling it to quarantine disease by "sacrificing" infected polyps. This response 323 likely prevents pathogens from spreading to the rest of the colony through the 324 common gastrovascular system, similar to plant hypersensitive resposne 41 The question of chemotaxis is also relevant to the accumulation of pathogens at the 379 coral pharynx. Significantly, while pathogen accumulation at lesion sites was only 380 observed 45-60 minutes from inoculation, comparable accumulation at the coral 381 pharynx is observed already 10-15 minutes into the experiment, suggesting 382 different mechanism may be driving the two phenomena. We suggest that 383 accumulation at the pharynx may be driven by the active uptake of water into the 384 coral's gastrovascular system prior to polyp contraction, as part of ongoing feeding 385 and gas exchange processes 37, 55-57 . Once inside the gastrovascular channels, where 386 flow is likely to be laminar and boundaries within easy reach, chemotaxis may well 387 play a part in bacterial colonization of the gastrovascular mucus. 388
The use of small coral fragments in our system allowed us to perform a relatively 389 large number of experiments, using fragments from multiple colonies. An 390 unexpected result was the heterogeneity in the response of different P. damicornis 391 colonies to V. coralliilyticus infection (Supplementary Table 1 ). While some colonies 392
were highly susceptible to infection (e.g. colonies 2 and 5), other colonies had 393 remarkably high survival rates (e.g. colonies 3 and 4). The mechanisms underlying 394 these differences are not clear. 
Methods
428
MCI experimental setup 429
Microfluidic chambers were fabricated in-house as follows: A 5x1.5 cm slab was cut 430 out of a 5 mm thick sheet of polydimethylsiloxane (PDMS) silicone elastomer 431 (Sylgard® 184) using a utility knife. 4-6 Ø8mm wells were punched into the 432 resulting slab using a biopsy punch of the same diameter, forming chambers of 433 approximately 250L. Inlet and outlet holes were punched into opposing sides of 434 each chamber using a 1 mm biopsy punch (Integra®, Fischer Scientific). 435 (Supplementary figure 1) . The PDMS slab was then bonded to a glass microscope 436 slide by exposing both to oxygen plasma for one minute using a laboratory Corona 437
Treater (Electro-Technic Products). Each chamber was fitted with polyethylene inlet 438 and outlet tubing (BPE-60, Instech Laboratories) (Fig 1) . The assembled device was 439 placed on a temperature controlled microscope stage. Small P. damicornis fragments 440 (3-5 mm) were placed in each chamber and chambers sealed with ApopTag® Plastic 441 cover slips (Merck). Flow (2.6 mL hour -1 ) was generated using a peristaltic pump 442 
Image analysis
486
Image analysis was carried out using imageJ (FIJI), by measuring mean grey 487 intensity (in pixels) of the entire frame in each channel (GFP, Chlorophyl, and 488 DsRed) captured at every time point. 489
Downstream exudate analysis 490
To couple the visual observations with direct microbial and biochemical 491 measurements, each chamber's effluents was continuously collected in a time 492 resolved manner using a fraction collector and immediately cooled to between 0 493 and 2 o C (Figure 1, step 5) . Odd numbered fractions (1.3 mL) each were immediately 494 fixed in 1% PFA in FASW. 20 μL of each sample was diluted 10 fold and stained with 495 nucleic acid stain SYBR-gold (Invitrogen). Cell abundance was measured using a 496 flow cytometer (iCyt Eclipse, excitation: 488 nm, emission: 500-550 nm). Even 497 numbered fractions were collected with no fixation and filtered through 0.22 μm 498 syringe filter (Millipore). Filtrate was used to estimate MMP activity using a specific 499 fluorescent substrate (Calbiochem MMP-2/MMP-7 Substrate, Fluorogenic) in a 500 microplate reader (Tecan Infinite® M200pro). Fluorescence (exitation :325 nm, 501 emmition: 393 nm) was measure every 90 seconds at 30 o C for 40 min. We used a 502
specific MMPs substrate to demonstrate that isolated V. coralliilyticus secretes 503
MMPs to the culture medium during different growth phases (Supplementary figure  504   6A ). This specific activity was confirmed by inhibition with GM6001, a broad-505 spectrum MMPs inhibitor with inhibition capacity of IC50 = 5 μM (Supplementary 506 figure 6B ). 
